Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats

International Journal of Fertility and Sterility

Mohammad Matinfar¹  Sara Soleimani Asl²  Roshanak Aboutorabi³  Fatemah Sadat Mostafavi⁴  Nahid Eskandari⁵  Abbas Bakhteyari⁵  Parvaneh Nikpour⁶ 

[1] 4Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran;5Department of Internal Medicine Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran;6Endometrium and Endometriosis Research Center, Hamedan University of Medical Sciences, Hamedan, Iran;Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicabl;Department of Anatomical Sciences, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran;Department of Genetics and Molecular Biology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran;

关键词: diabetes mellitus;    embryo implantation;    metformin;    pioglitazone;    tumor necrosis factor;    alpha;   

DOI  :  10.22074/ijfs.2019.5636

来源: DOAJ

【 摘 要 】

Background The present study was designed to evaluate serum lipid profile and tumor necrosis factor-alpha (TNF-ɑ) level in diabetic rats at implantation time. Type 2 diabetes mellitus (T2DM) could affect various systems, including innate immune system and it causes chronic low-grade inflammation, increasing level of TNF-ɑ. Furthermore, T2DM is often accompanied by impaired lipid profile. Metformin and pioglitazone are used as the first and second lines of treatment for T2DM. Materials and Methods In this experimental study, 35 adult virgin female wistar rats, weighting 175-225 g, were randomly categorized into five groups: i. Control, ii. Sham, iii. Nicotinamide (NA)+streptozotocin (STZ) induced T2DM, iv. Diabetic+pioglitazone (20 mg/kg/day for 28 days oral administration), and v. Diabetic+metformin (100 mg/kg/day for 28 days oral administration). At the time of implantation, TNF-ɑ level in serum of rats was measured by ELISA kit. Glucose was measured using photometric method and lipid profiles were calculated by enzymatic methods. Results Level of TNF-ɑ in the diabetic group was significantly higher than other groups (P < 0.001). In metformin treated group, TNF-ɑ serum level was also significantly higher than pioglitazone treated group (P < 0.001). Fasting blood sugar (FBS) and lipid profiles were significantly higher in diabetic group. Conclusion Metformin and pioglitazone have similar effects on glucose, lipid profiles and TNF-ɑ serum levels. Among these drugs, pioglitazone has more efficient influence on TNF-α serum level, in comparison with metformin.

【 授权许可】

Unknown